Aliskiren – an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension

There has been enormous progress in antihypertensive therapy over the last few decades. However, the management of arterial hypertension is still insufficient and more efforts are needed to improve both non-pharmacological and pharmacological treatment of this widely prevalent disease. Renin-angiote...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaporowska-Stachowiak, Iwona, Hoffmann, Karolina, Bryl, Wiesław, Minczykowski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175758/
https://www.ncbi.nlm.nih.gov/pubmed/25276171
http://dx.doi.org/10.5114/aoms.2013.34723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175758/
https://www.ncbi.nlm.nih.gov/pubmed/25276171
http://dx.doi.org/10.5114/aoms.2013.34723

Ejemplares similares